Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Analysis finds GLP-1 drugs for weight loss don’t justify their price after 2 years
Study of patients who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the medications.
New York City Utterly Screwed Up Insurance for Employees Taking GLP-1 Weight Loss Drugs
After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and their dependents began using the drugs — and now, they're being told that coverage was accidental.
Big Food Is Learning to Love Weight-Loss Drugs
A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do indeed eat less—especially indulgent treats.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic.
Ozempic and other weight loss drugs aren't lowering health care costs yet
GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.
How Much Does Ozempic Cost Without Insurance Compared to Other Weight Loss Drugs?
11h
on MSN
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...
10h
Ars Live: Join us Tuesday as we discuss GLP-1 drugs—insights and unknowns
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...
STAT
11h
In the era of GLP-1 drugs, demand for bariatric surgery plunges
The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...
Medpage Today on MSN
1d
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids
Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...
The Economist
1d
It’s not just obesity. Drugs like Ozempic will change the world
First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...
STAT
2d
More state Medicaid programs consider covering GLP-1 drugs
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...
11d
on MSN
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozempic
American Heart Association
Feedback